Who this is for
Competitive intelligence and strategy teams
Spend your time on implications and scenarios. The matrix, the pipeline view and the catalyst calendar stay current without a weekly rebuild.
Brand and franchise leadership
Know what the competition will do next, with enough lead time to plan for it, and see each competitor event in the context of your own brand.
Business development and licensing
Follow deals, partnerships and pipeline assets across the therapy area, so opportunities and threats show up before the announcement.
Medical and market access
See competitor readouts, label changes and coverage decisions in the same place as the commercial team, so both sides of the house respond from the same facts.
What changes for the team
How the work tends to look today, and how it looks once Pharma Landscape 360 is in place.
How Pharma Landscape 360 helps
A competitor matrix that stays current
Your product and its competitors side by side: label and indications, positioning, the evidence behind them, pricing and access, safety, and what is coming next for each. When something changes, the matrix changes, and the change is flagged rather than quietly overwritten. It is the slide everyone asks for, kept up to date without anyone rebuilding it.
The catalyst calendar
Approval decisions, advisory committees, data readouts, congress presentations, patent expiries and launches for the products you follow, on one timeline running eighteen months ahead. The brand plan, the medical plan and the forecast can all be built around events the team can see coming.
Pipeline and deal tracking
Follow what is coming behind the marketed competitors: assets by phase and expected timing, the trials that will read out, and the licensing deals, partnerships and acquisitions that change who owns what. Business development and strategy see the same pipeline the brand team does.
From event to implication
Every week the summary sets out what changed and why it matters for your brand. When something significant happens, a brief can be produced in minutes that puts the event in context: how it compares, what it might change, and what to watch next. The CI team adds the judgment. The platform has already done the assembly.
One picture, many audiences
Brand teams, medical, market access, business development and leadership each see the competitive picture through their own workspace, and briefs can be exported for meetings in a few clicks. Everyone argues about what to do rather than about whose version of the facts is correct.
An example
A competitor files earlier than expected
On a Wednesday morning a competitor announces that its regulatory submission for a new indication has been accepted, two quarters earlier than the market expected. If approved, it would compete directly with your brand's next launch.
The brand lead, the CI lead and the head of market access are told the same morning. The catalyst calendar updates with the expected decision date, and the competitor matrix shows the change alongside the evidence behind the competitor's filing.
By early afternoon the CI team has turned the generated brief into a short assessment for the leadership meeting: how the competitor's data compares, when a decision is likely, and what the launch team should consider bringing forward. The meeting spends its time on the decision, not on establishing the facts.
Common questions
If yours isn't here, ask us directly.
What is pharma competitive intelligence?
It is the ongoing work of understanding what competing products and companies are doing, and what that means for your own brands and pipeline. In pharma it covers pipelines, trials, regulatory decisions, labels, pricing and access, deals and patents, and it informs decisions across brand, medical, market access and business development.
How is this different from a news alert service?
A news service tells you that something happened. Pharma Landscape 360 places it in context: which of your products it affects, how it compares with what you have, where it sits on the calendar, and what has changed since last week. It also keeps the underlying picture current, which a stream of headlines cannot.
Is the information gathered legally and ethically?
Yes. Pharma Landscape 360 works only with information that is publicly available, and it is built to be used within the ethical standards that competitive intelligence professionals follow.
How far ahead does the catalyst calendar look?
Eighteen months, covering approval decisions, readouts, congress presentations, patent expiries and launches for the products and competitors you follow.
Can we follow more than one therapy area?
Yes. Each therapy area or brand can have its own set-up, and teams that work across several can see them side by side.
Does it replace our CI team or agency?
No. It gives them a better starting point. The routine tracking and assembly are handled, so their time goes into interpretation, scenario work and the questions that need experience.
Further reading
Glossary: Catalyst calendar, Competitive intelligence, Complete response letter, Loss of exclusivity, Orphan drug designation, PDUFA date